Respiforb® Combi

Pulmonology

Respiforb® Combi

Registration certificate:

INN:

Budesonide + Formoterol [kit]

Release form:

Inhalation powder hard capsule set

Therapeutic Area:

Pulmonology

Pharmacotherapeutic Group:

Combined bronchodilator (beta-2-selective adrenomimetic + local glucocorticosteroid)

Conditions for dispensing:

On prescription

Packaging:

Indications:

Bronchial Asthma
Chronic Obstructive Pulmonary Disease (COPD) (with proven efficacy of corticosteroids)

Respiforb^® Combi is in the Essential Medicines List